Previous 10 | Next 10 |
RANCHO CUCAMONGA, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies London Healthcare Conference on Thursday, November 21, 2019 at 3:20 p.m. GMT in Aldwych, London, UK. ...
Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2019 Earnings Conference Call November 7, 2019 17:00 ET Company Participants Jason Shandell - President Bill Peters - CFO Conference Call Participants David Amsellem - Piper Jaffray Gary Nachman - BMO Capital Markets David Steinbe...
MannKind ( MNKD ) reported its Q3 earnings last week, and for the most part the company metrics were in line with the projections I have outlined. The company reported revenue of $14.6 million, which included $5.7 million in Afrezza net revenue from the United States and $700,000 in Afrezza ne...
Image source: The Motley Fool. Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q3 2019 Earnings Call Nov 7, 2019 , 5:00 p.m. ET Operator Continue reading
Reports Net Revenues of $80.1 Million for the Three Months Ended September 30, 2019 RANCHO CUCAMONGA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three...
RANCHO CUCAMONGA, Calif., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its third quarter of 2019 ended September 30th, 2019, after the market closes on Thursday, November 7th, 2019, and will hold a confe...
Shares of Amphastar ( AMPH ) have performed relatively well since my last check-in over three months ago, up about 19% compared to a gain of 6.6% for the S&P 500. My previous view on the company was overwhelmingly neutral, and in spite of a nearly $60 million settlement with Sandoz ( N...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this Read more ...
RANCHO CUCAMONGA, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President, and Bill Peters, CFO, will be presenting at the Wells Fargo 2019 Healthcare Conference on Thursday, September 5, 2019 at 3:05 p.m. Easte...
As many readers know, I have covered the MannKind ( MNKD ) story for quite some time. Over the years I have outlined various projections and models with a particular focus on the cash situation and cash flows at MannKind. Subsequent to the termination of the Sanofi ( SNY ) deal, MannKind fou...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
At the Needham Healthcare Conference, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) highlighted why they remain excited about Baqsimi, the ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 1, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside c...
2024-03-20 15:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...